Showing results (21-30 of 108) with videos related to

Sort By:
Pageof 11
Diabetologia|November 27, 2004
The PlA1/A2 polymorphism of platelet glycoprotein IIIa is not associated with the risk of type 2 diabetes. The Ludwigshafen Risk and Cardiovascular Health studyW März, B O Boehm, B R Winkelmann, et al.
Journal of Immunological Methods|March 31, 1998
Analysis of the alpha/beta T-cell receptor repertoire by competitive and quantitative family-specific PCR with exogenous standards and high resolution fluorescence based CDR3 size imagingB J Manfras, W A Rudert, M Trucco, et al.
Acta Endocrinologica|June 1, 1991
HLA-DR3 and variations of the T cell receptor beta gene in Graves' diseaseE Schifferdecker, B Manfras, P Kühnl, et al.
Acta Diabetologica|January 22, 2005
T-cell receptor repertoire and function in umbilical cord blood lymphocytes from newborns of type 1 diabetic mothersB J Manfras, S Claudi-Boehm, R Kreienberg, et al.
Clinical Endocrinology|January 7, 2010
Association of vitamin D status with serum androgen levels in menE Wehr, S Pilz, B O Boehm, et al.
Cancer Letters|July 14, 2000
Role of the MEN1 tumour suppressor gene in human ductal pancreatic cancerW Karges, S Maier, F Schmidt, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|December 16, 1998
DNA vaccination with glutamic acid decarboxylase (GAD) generates a strong humoral immune response in BALB/c, C57BL/6, and in diabetes-prone NOD miceU Wiest-Ladenburger, A Fortnagel, W Richter, et al.
Clinical and Experimental Immunology|September 1, 2001
Autoantibodies from patients with coeliac disease recognize distinct functional domains of the autoantigen tissue transglutaminaseJ Seissler, U Wohlrab, C Wuensche, et al.
The Journal of Clinical Endocrinology and Metabolism|March 10, 2001
Genotype-phenotype correlations in hereditary medullary thyroid carcinoma: oncological features and biochemical propertiesA Machens, O Gimm, R Hinze, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|August 19, 2007
The HMG-CoA reductase inhibitor cerivastatin lowers advanced glycation end products in patients with type 2 diabetesH Scharnagl, T Stojakovic, K Winkler, et al.
Pageof 11